Financial news: Technology

Latest News

Live

07:59pm	Russia's Yandex says supercomputers were not damaged in drone attacks	RE
06:56pm	Poland eyes more cooperation with Germany in space, Polish minister says	RE
06:54pm	Obesity drug developer Corxel to go public in US via SPAC deal	RE
05:40pm	AstraZeneca highlights advances across cancer portfolio at ESMO 2026	AN
03:27pm	STMicroelectronics launches sensors for automotive safety
02:24pm	PRESS DIGEST-Wall Street Journal - October 26	RE
09:49am	Japanese companies compensate users as cyberattacks buffet economy	RE
07:20am	Zelenskiy says US fully resumes warnings on ballistic strikes	RE
10-25	Astrazeneca plc Reports Positive Results from Clarity-Gastric01 Global Phase Iii Trial of Sonesitatug Vedotin in Cldn18.2-Positive Advanced Gastric Cancers	CI
10-25	Netanyahu rebuked for plan to use crypto to bypass economic sanctions	RE
10-25	Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors	CI
10-24	Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors	CI
10-24	Who gets paid to rearm the West?
10-24	Bayer Reports Interim Analysis Results From The Phase III DASL-HiCaP Trial Of NUBEQA Plus ADT And Radiation Therapy In Prostate Cancer Patients At High Risk Of Recurrence	CI
10-24	With his first smartphone, Lula seeks to catch up to Brazil's online generation	RE
10-24	Compass Therapeutics Announces Publication Of Phase 2/3 COMPANION-002 Results For Tovecimig In The Journal Of Clinical Oncology And Oral Presentation At ESMO 2026	CI
10-24	Shanghai Junshi Biosciences Co., Ltd Announces Completion Of First Patient Dosing In Phase 3 Clinical Trial Of JS203 In Combination With Chemotherapy For Treatment Of Diffuse Large B-Cell Lymphoma	CI
10-24	SpaceX's satellite connection renewed at over 400 km/h, Ukraine's defence minister says	RE
10-24	OpenAI resumes frontier AI training after security overhaul, discloses flaw in widely used software	RE
10-24	US has for years asked Musk to alter Starlink service in Ukraine, Middle East, sources say	RE
10-24	PHP Foundation 'under-funded' with one full-time staff member, director says	RE
10-24	AlixPartners Co-CEO Rob Hornby on AI Bull Case	MT
10-24	Pasithea Therapeutics Corp. Announces Positive PAS-004 Clinical Data From Phase 1 Advanced Cancer Study Presented At ESMO Congress 2026	CI
10-24	TG Therapeutics, Inc. Announces Phase 1 Data Evaluating Azer-Cel in Progressive Multiple Sclerosis At MSToronto2026	CI
10-24	Eikon Therapeutics, Inc. Presents Initial And Updated Data For EIK1003, EIK1004 And EIK1005 At The 2026 European Society For Medical Oncology Congress	CI
10-24	Bristol Myers Squibb Presents Interim Safety and Efficacy Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel in Multiple Sclerosis	CI
10-24	Belden Inc. And Radiflow Partner To Close The Gap Between OT Threat Detection And Network Response	CI
10-24	Vertex Pharmaceuticals Incorporated Publishes Phase 3 RAINIER Results For Povetacicept In IgA Nephropathy And Advances Povetacicept Clinical Research Program In IgAN	CI
10-24	Mark Cuban says AI hack agents are like cockroaches, but can be controlled	RE
10-24	Novartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib	RE
10-24	Iran has detailed plans to hit Gulf undersea cables if war resumes, officials say	RE
10-24	PwC confirms cybersecurity incident involving employee learning records	RE
10-24	Novartis Says MS Pill Helped Control Disease With Favorable Safety Data in Trials	DJ
10-24	AT&T, T-Mobile tighten AI guardrails as autonomous networks remain years away	RE
10-24	A Biosynex subsidiary secures $5.7m in financing
10-23	Bank of Italy calls for digital asset investments by banks despite uncertainty	RE
10-23	AI in Early Stages of a Bubble, Gabelli's Marangi Says	MT
10-23	Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile	DJ
10-23	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
10-23	Iran shows off purported underground drone factory in state TV footage	RE
10-23	Wells Fargo, Intuit latest companies to object to their shares being tokenized, document shows	RE
10-23	Ukraine says Starlink speed curbs remain despite Trump assurance	RE
10-23	Wells Fargo, Intuit others object to their shares being tokenized- regulatory document	RE
10-23	Iovance Biotherapeutics, Inc. Presents New Data Demonstrating Deep, Durable Responses With Lifileucel TIL Cell Therapy Plus Pembrolizumab In Frontline Advanced Melanoma	CI
10-23	Wall Street regulator to focus on AI, private assets in corporate exams	RE
10-23	Denmark's digital reliance leaves it exposed to cyberattacks, minister says	RE
10-23	Navigate360 says hackers accessed system, potentially exposed sensitive personal data	RE
10-23	Humacyte, Inc. Announces Positive Interim Results from the V012 Phase 3 Clinical Trial of the Acellular Tissue Engineered Vessel in Arteriovenous Access for Female Hemodialysis Patients	CI
10-23	Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development	RE
10-23	Nexxen International Ltd. And Brainlabs Leverage Smart TV Home Screen Advertising To Expand Audience Reach	CI

Become a member to access more news

New member

No results match your criteria

Most Mentioned (24h)

STMICROELECTRONICS N.V.	+2.93%
ASTRAZENECA PLC	+0.02%
NEBIUS GROUP	+3.37%
	-
AMANAT ACQUISITION CORP	-0.49%
GMO INTERNET GROUP, INC.	-15.65%

Headlines

	CSPC Pharma, Alphamab Oncology Unit's Gastric Cancer Drug Trial Results Presented at 2026 ESMO Meeting
	Global markets live: SpaceX, Tesla, Verizon, Bayer…
	China Shenhua Energy Plans Up to 30 Billion Yuan Debt Issuance
	HKMA Designates 12 Primary Liquidity Providers, Expands Yuan Repo Facility to 22 Billion Yuan
	Correction to Bayer Update
	Ping An Bank, Ping An Health to Sign Related-Party Deals Worth Up to 69.9 Billion Yuan
	Sinoma Proposes to Raise Subsidiary's Capital By 1.79 Billion Yuan; Shares Down 8%
	SpaceX Pricing Bonds at Up to 8.75%
	Microsoft is offering buyouts to around 60,000 employees, Business Insider reports
	Inside the Audi CEO backlash after joining Trump at midterm campaign rally

As early as today, start finding the best investment opportunities!